(GALE) Galenica Sante - Ratings and Ratios

Galenica Sante AG (SW:GALE) is a Swiss healthcare service provider with a dual focus on patient care and logistics. The company operates through two distinct segments: Products & Care and Logistics & IT. The Products & Care division manages a network of pharmacies and partner pharmacies under the Amavita, Sun Store, and Coop Vitality brands. It also specializes in home medication services, distributes consumer health and pharmaceutical products, and provides marketing support to healthcare partners. This segment is essentially the consumer-facing arm of Galenica, ensuring that patients have access to essential healthcare products and services.

The Logistics & IT segment is the backbone of Galenicas operations, offering pre-wholesale services such as storage, distribution, and debt collection for pharmaceutical companies. It also develops and maintains a master data system for the healthcare market, providing critical infrastructure for the industry. Additionally, this segment offers IT services to the group and publishes technical information on pharmaceutical products, ensuring that healthcare professionals have access to accurate and up-to-date information. This division is a key differentiator for Galenica, as it combines logistics expertise with technological solutions to streamline healthcare operations.

Founded in 1927 and headquartered in Bern, Switzerland, Galenica has a long history of stability and innovation in the healthcare sector. With a market capitalization of 4063.82M CHF, the company is a significant player in the Swiss healthcare market. Its current P/E ratio of 23.99 and forward P/E of 20.79 suggest that investors are pricing in expectations of steady growth. The P/B ratio of 2.89 indicates that the market values the companys assets at a premium, likely due to its strong market position and diversified business model. The P/S ratio of 1.07 reflects moderate revenue scalability relative to its market value.

For investors and fund managers, Galenicas dual-segment approach provides a balanced exposure to both consumer healthcare and B2B logistics. The companys ability to integrate technology into its operations